June 29, 2020

As an advocate for consumers across the country, CASE urges House lawmakers to vote against H.R. 1425, the Patient Protection and Affordable Care Enhancement Act. This backwards proposal prioritizes insurers over patients and adds more price controls on prescription medicines that will hurt patients and crush American medical innovation at a time when we can least afford it. By eliminating competing plans and tying Medicare prices to those in socialized nations abroad, costs will go up, and patients will lose the quality of care and access to lifesaving cures that have made this country the best place in the world to be treated. We urge lawmakers to reconsider this proposal and instead work to eliminate additional government intervention that only hurts consumers.